The legacy success of sildenafil has undeniably shaped the drug landscape. However, wagering in companies heavily dependent on biosimilars and the diminishing patent exclusivity surrounding this iconic https://bookmarkspring.com/story16548202/the-blue-pill-and-drugmakers-a-speculative-investment